A detailed history of Rafferty Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 65,451 shares of KYMR stock, worth $2.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,451
Previous 90,820 27.93%
Holding current value
$2.67 Million
Previous $2.71 Million 14.28%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.16 - $52.4 $765,129 - $1.33 Million
-25,369 Reduced 27.93%
65,451 $3.1 Million
Q2 2024

Aug 13, 2024

SELL
$29.85 - $39.42 $3.58 Million - $4.73 Million
-120,041 Reduced 56.93%
90,820 $2.71 Million
Q1 2024

May 13, 2024

BUY
$22.9 - $43.57 $2.08 Million - $3.95 Million
90,672 Added 75.44%
210,861 $8.48 Million
Q4 2023

Feb 13, 2024

SELL
$10.97 - $26.84 $328,112 - $802,784
-29,910 Reduced 19.93%
120,189 $3.06 Million
Q3 2023

Nov 13, 2023

SELL
$13.9 - $23.88 $895,034 - $1.54 Million
-64,391 Reduced 30.02%
150,099 $2.09 Million
Q2 2023

Aug 11, 2023

BUY
$22.4 - $34.92 $120,982 - $188,602
5,401 Added 2.58%
214,490 $4.93 Million
Q1 2023

May 11, 2023

SELL
$24.84 - $38.75 $161,112 - $251,332
-6,486 Reduced 3.01%
209,089 $6.2 Million
Q4 2022

Feb 13, 2023

BUY
$19.57 - $30.92 $703,208 - $1.11 Million
35,933 Added 20.0%
215,575 $5.38 Million
Q3 2022

Nov 14, 2022

BUY
$20.91 - $34.27 $612,725 - $1 Million
29,303 Added 19.49%
179,642 $3.91 Million
Q2 2022

Aug 12, 2022

BUY
$14.13 - $42.55 $370,361 - $1.12 Million
26,211 Added 21.12%
150,339 $2.96 Million
Q1 2022

May 13, 2022

BUY
$35.3 - $64.68 $1 Million - $1.83 Million
28,352 Added 29.6%
124,128 $5.25 Million
Q4 2021

Feb 10, 2022

BUY
$49.91 - $65.56 $2.45 Million - $3.21 Million
49,027 Added 104.87%
95,776 $6.08 Million
Q3 2021

Nov 10, 2021

SELL
$47.8 - $66.66 $231,925 - $323,434
-4,852 Reduced 9.4%
46,749 $2.75 Million
Q2 2021

Aug 10, 2021

SELL
$31.08 - $51.95 $6,495 - $10,857
-209 Reduced 0.4%
51,601 $2.5 Million
Q1 2021

May 10, 2021

BUY
$35.64 - $85.46 $1.85 Million - $4.43 Million
51,810 New
51,810 $2.01 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.23B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.